Integrative Unani Management of Secondary Infertility: A Case Report of Reproductive Recovery

Secondary infertility (Uqur-e-Sanwi) is the inability to conceive after a previous pregnancy, regardless of its outcome. In Unani medicine it is discussed under the broader term Uqur (sterility), which classical scholars such as Buqrat (Hippocrates), Ibn Sina (Avicenna), Jurjani, and Zakariya Razi categorized into Uqur-e-Mutlaq (absolute sterility) and Uqur-e-Nisbi (relative sterility). The Unani formulations used in this report are Habb-e-Hamal and Majun-e-Hamal Ambari (Muqawwi-e-Rahem, uterine tonics), Dawa-ul-Misk Motadil (Jawahar Wala) (Muqawwi-e-Meda and Muqawwi-e-Qalb), and Majun-e-Supari Paak (Qabid and Muqawwi-e-Rahem). In this case report, a 26-year-old woman, gravida 2, para 1, abortus 1 (G2P1A1), presented with a history of unsuccessful conception attempts for over one year following a spontaneous abortion in 2023. She had previously delivered a healthy full-term infant in 2022. Comprehensive evaluation, including hormonal profiling, pelvic ultrasonography, and her spouse’s semen analysis, revealed no abnormalities, leading to a diagnosis of unexplained secondary infertility. The treatment protocol included Habb-e-Hamal (2 tablets [400 mg per tablet ]) twice daily from day 2 to day 12 of the menstrual cycle), Majun-e-Hamal Ambari (5 gm twice daily for one month starting on day 2 of the cycle), and Dawa-ul-Misk Motadil (Jawahar Wala) (5 gm twice daily for one month starting on day 2 of the cycle). Upon ultrasonographic confirmation of dominant follicle rupture, Majun-e-Supari Paak (5000 mg twice daily for one month) was prescribed. Conception occurred after just one treatment cycle. The pregnancy progressed without complications, and the patient delivered a healthy baby by lower segment caesarean section in January 2026.

Authors

Publication Details

Journal
International Journal of AYUSH Case Reports
Published
2026-11-15
DOI
https://doi.org/10.70805/wc7nsk98
Primary Topic
Traditional Chinese Medicine Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Integrative Unani Management of Secondary Infertility: A Case Report of Reproductive Recovery

Amreen Begum, S. Sultana, Zeba Lalkot, Syeda Abidunnisa
International Journal of AYUSH Case Reports
Traditional Chinese Medicine Studies
article

Integrative Unani Management of Secondary Infertility: A Case Report of Reproductive Recovery

Amreen Begum, S. Sultana, Zeba Lalkot, Syeda Abidunnisa
article en

Abstract

Secondary infertility (Uqur-e-Sanwi) is the inability to conceive after a previous pregnancy, regardless of its outcome. In Unani medicine it is discussed under the broader term Uqur (sterility), which classical scholars such as Buqrat (Hippocrates), Ibn Sina (Avicenna), Jurjani, and Zakariya Razi categorized into Uqur-e-Mutlaq (absolute sterility) and Uqur-e-Nisbi (relative sterility). The Unani formulations used in this report are Habb-e-Hamal and Majun-e-Hamal Ambari (Muqawwi-e-Rahem, uterine tonics), Dawa-ul-Misk Motadil (Jawahar Wala) (Muqawwi-e-Meda and Muqawwi-e-Qalb), and Majun-e-Supari Paak (Qabid and Muqawwi-e-Rahem). In this case report, a 26-year-old woman, gravida 2, para 1, abortus 1 (G2P1A1), presented with a history of unsuccessful conception attempts for over one year following a spontaneous abortion in 2023. She had previously delivered a healthy full-term infant in 2022. Comprehensive evaluation, including hormonal profiling, pelvic ultrasonography, and her spouse’s semen analysis, revealed no abnormalities, leading to a diagnosis of unexplained secondary infertility. The treatment protocol included Habb-e-Hamal (2 tablets [400 mg per tablet ]) twice daily from day 2 to day 12 of the menstrual cycle), Majun-e-Hamal Ambari (5 gm twice daily for one month starting on day 2 of the cycle), and Dawa-ul-Misk Motadil (Jawahar Wala) (5 gm twice daily for one month starting on day 2 of the cycle). Upon ultrasonographic confirmation of dominant follicle rupture, Majun-e-Supari Paak (5000 mg twice daily for one month) was prescribed. Conception occurred after just one treatment cycle. The pregnancy progressed without complications, and the patient delivered a healthy baby by lower segment caesarean section in January 2026.

International Journal of AYUSH Case Reports
Traditional Chinese Medicine Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon